Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

Recruiting now

Conditions studied: Severe Aortic Valve Stenosis, Valvular Heart Disease, Aortic Valve Stenosis

In brief

This study is designed to evaluate the success rate of transfemoral implantation of the Hydra THV biological aortic valve prosthesis in patients with severe symptomatic aortic stenosis. The device is used in accordance with its Instructions for Use as a CE-marked transcatheter heart valve system. The study will assess procedural success, device performance, and early clinical outcomes following implantation. Patients undergoing transcatheter aortic valve replacement (TAVR) via the transfemoral approach will be followed to evaluate safety and effectiveness outcomes, including short- and mid-term clinical follow-up.

Key facts

Study ID
NCT07566624
Run by
Fundación EPIC
People needed
100
Starts
2026-07-07
Expected to finish
2029-02-01
Last updated by the study team
2026-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.